Nasdaq · Healthcare
COMPUGEN LTD (CGEN)
As-reported financials and recent SEC filings for COMPUGEN LTD, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$72.8M
Net income
$35.3M
Net margin
48.6%
Diluted EPS
$0.38
ROE
34.4%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $72.8M | $27.9M | $33.5M | $7.5M | $6.0M |
| Gross profit | $63.5M | $19.9M | — | $6.5M | $5.3M |
| Operating income | $31.3M | $-14.9M | $-13.0M | $-35.4M | $-35.1M |
| Net income | $35.3M | $-14.2M | $-18.8M | $-33.7M | $-34.2M |
| Diluted EPS | $0.38 | $-0.16 | $-0.21 | $-0.39 | $-0.41 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
EFFECT2026-06-08
View on EDGAR →F-32026-05-18
View on EDGAR →6-K2026-05-18
View on EDGAR →1442026-04-27
View on EDGAR →1442026-04-27
View on EDGAR →42026-04-27
View on EDGAR →42026-04-27
View on EDGAR →1442026-04-15
View on EDGAR →Largest Healthcare peers
Go deeper on CGEN
Search COMPUGEN LTD’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.